Jackson Acquisition Company II

What they do

Jackson Acquisition Co II is a Cayman Islands exempted blank check company incorporated on September 11, 2024, formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. The company completed its IPO on December 11, 2024, selling 23,000,000 units at $10.00 per unit, generating $230 million in gross proceeds, and simultaneously sold 840,000 private placement units for $8.4 million. The company has not yet selected a target business and has no revenue; its sole activity is identifying and evaluating acquisition candidates.

Revenue drivers

• Trust Account interest income — The company holds IPO and private placement proceeds in a trust account that earns interest income on marketable securities; this is the only source of income, and it funds operations until a business combination.
• No operating revenue — The company has no operating revenues and does not expect to generate any until after a business combination; revenue generation will depend on the future acquired business.
• Potential business combination target — The company intends to generate returns for shareholders through an initial business combination, focusing on healthcare services, healthcare technology, or the healthcare industry, but no target has been identified.

Recent performance

For the six months ended June 30, 2026, the company reported net income of $3,949,131, consisting of $4,301,982 of interest earned on trust account marketable securities offset by $352,851 of general and administrative expenses. For the three months ended June 30, 2026, net income was $1,980,048, with $2,164,627 of interest income and $184,579 of G&A expenses. For the six months ended June 30, 2025, net income was $4,545,737, with $4,881,095 of interest income and $335,358 of G&A expenses. As of June 30, 2026, total assets were $247.3 million, cash and equivalents were $358,338, and shareholder equity was negative at $-132,101.

Strategy

The company plans to focus its search on high-quality businesses in healthcare services, healthcare technology, or otherwise focused on the healthcare industry. It intends to use cash from the IPO and private placement proceeds held in trust, along with potential debt or securities, to effect a business combination. Management has broad discretion in applying proceeds not held in trust, but substantially all net proceeds are intended for consummating a business combination and working capital. The company's goal is to identify a fundamentally healthy business and work with it to access capital markets, attract management, and execute a value-creation plan.

Risks

• No target identified — The company has not selected any target business for its initial business combination and cannot assure success in completing one.
• Need for additional financing — The company may need to obtain additional financing to complete a business combination, which may not be available on acceptable terms.
• Negative shareholder equity — As of June 30, 2026, the company had negative shareholder equity of $-132,101, driven by formation and operating costs exceeding modest income.
• Limited operating history — The company has no operating history and has incurred losses since inception; it may not be able to generate sufficient returns for public shareholders.

Outlook

Management expects to continue incurring significant costs in pursuing acquisition plans and cannot assure that a business combination will be completed. The company will rely on interest income from the trust account and working capital to fund operations. No specific timeline or target has been disclosed.